The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125384993 12538499 3 F 20160324 20160714 20160707 20160720 EXP US-BIOGEN-2015BI108225 BIOGEN 25.46 YR F Y 0.00000 20160720 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125384993 12538499 1 PS TYSABRI NATALIZUMAB 1 Intravenous (not otherwise specified) INFUSED OVER 1 HOUR 125104 300 MG CONCENTRATE FOR SOLUTION FOR INFUSION
125384993 12538499 2 SS TYSABRI NATALIZUMAB 1 Intravenous (not otherwise specified) 125104 300 MG UNKNOWN

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125384993 12538499 1 Multiple sclerosis

Outcome of event

Event ID CASEID OUTC COD
125384993 12538499 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125384993 12538499 Maternal exposure during pregnancy
125384993 12538499 Prolonged labour

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125384993 12538499 1 20130826 20150702 0